| Glucosidase inhibitors |
Valid Value (%) |
NV/NA (%) |
|
| Valid Value |
48738 ( 75.4) |
0 ( 0.0) |
48738 ( 75.4) |
| NV/NA |
15899 ( 24.6) |
0 ( 0.0) |
15899 ( 24.6) |
|
64637 (100.0) |
0 ( 0.0) |
64637 (100.0) |
Table 5.2.9.3.1 : Glucosidase inhibitors (by Type of Diabetes)
| CMH Chi-Square |
p.value |
df |
| 16683.9414 |
0 |
1 |
|
Barplot 5.2.9.3.1 - Glucosidase inhibitors (by Type of Diabetes)
| Glucosidase inhibitors |
Type 1 (%) |
Type 2 (%) |
|
| Yes |
12 ( 0.3) |
2020 ( 4.5) |
2032 ( 4.2) |
| No |
4031 ( 99.7) |
42675 ( 95.5) |
46706 ( 95.8) |
|
4043 ( 8.3) |
44695 ( 91.7) |
48738 (100.0) |
Table 5.2.9.3.2 : Glucosidase inhibitors (by Type of Diabetes)
| CMH Chi-Square |
p.value |
df |
| 164.4139 |
0 |
1 |
|
Barplot 5.2.9.3.2 - Glucosidase inhibitors (by Type of Diabetes)
|
Barplot 5.2.9.3.2a - Glucosidase inhibitors (by Data Source, Type of Diabetes = Type 1)
|
Barplot 5.2.9.3.2b - Glucosidase inhibitors (by Data Source, Type of Diabetes = Type 2)
